Introduction
Class II major histocompatibility complex (MHC) molecules play an essential role in the body's immune response to pathogens. Once an antigen-presenting cell (macrophage, dendritic cell or B lymphocyte) captures an extracellular pathogen, the protein component is degraded into peptide fragments. Class II MHC molecules in the cell's interior bind to selected peptide fragments designated antigenic peptides or epitopes. The epitope/MHC complex travels to the cell surface where the MHC molecule displays the epitope to nearby CD4 T lymphocytes. When a CD4 T lymphocyte binds to an epitope/MHC complex, an immune response is initiated.
Each binding peptide is comprised of a linear arrangement of amino acid residues. Knowledge of the amino acid sequence of an epitope is useful in vaccine development and increases general understanding of the immune system. Finding a pattern or motif among epitopes that bind a particular MHC molecule allows for epitope prediction. A predictive model can be used to screen large numbers of potential binding peptides, thus reducing laboratory time and costs.
The challenge of predicting peptide/MHC binding involves numerous molecules and peptides. HLA, the human MHC molecule, is highly polymorphic. Over 200 types of HLA class I and class II molecules have been identified; however, many have been shown to share overlapping binding repertoires (Southwood et al., 1998) . Each position in a peptide fragment is occupied by one of 20 amino acid residues. Thus, a peptide of length n has 20 n possible configurations.
The class II MHC binding site has been shown to bind ligands of 9-25 residues. X-ray crystallography reveals that the binding site is open at both ends (Brown et al., 1993; Stern et al., 1994) . Consequently, given a class II MHC binding peptide, it is not known which segment is involved in the binding. An algorithm for motif derivation must involve proper alignment as well as motif extraction.
O 'Sullivan et al. (1991a,b) , Chicz et al. (1992) , Kropshofer et al. (1992) , Hammer et al. (1992 Hammer et al. ( , 1993 , Falk et al. (1994) , Fleckenstein et al. (1996) and Southwood et al. (1998) have studied the binding properties of the class II MHC allele HLA-DR1. In previous studies (Mallios, 1997 (Mallios, , 1998 , the present author introduced a data-driven procedure for predicting class II MHC binding with or without the use of an initial suggested motif.
This study utilizes a large Internet database. The four models developed for HLA-DR1 demonstrate the algorithm's versatility. Models can be developed with or without an expert initial estimate. The set of predictors can be limited to individual amino acid residues or can be extended to include residue groupings and other amino acid attributes.
Systems and methods

MHCPEP database
The MHCPEP database (Brusic et al., 1997 ) is a source for peptides known to bind MHC molecules. It is located on the Internet at http://wehih.wehi.edu.au/mhcpep/. The description reads: 'MHCPEP is a curated database comprising over 13000 peptide sequences known to bind MHC molecules. Entries are compiled from published reports as well as from direct submissions of experimental data. Each entry contains the peptide sequence, its MHC specificity and, when available, experimental method, observed activity, binding affinity, source protein, anchor positions, and publication references.' The 526 peptides that bind DR1 were downloaded for analysis in this study.
A database published by O'Sullivan et al. (1990) provides sets of non-binding peptides for DR1, DR2, DR5 and DR52a. Ninety-eight peptides that do not bind DR1 were obtained from this source.
The data-sets
The models developed here explore subsequences of length nine. Nine was selected for modeling DR1 because (i) many previous studies suggest motifs of length nine and (ii) the shortest sequences in the MHCPEP database that bind DR1 consist of nine amino acid residues.
The unique strategy employed here depends on building two working data-sets of subsequences: one set of probable binders and one set of probable non-binders. The non-binding data-set remains constant throughout the process. Based on the assumption that all subsequences of a non-binding peptide are themselves non-binding, the non-binding dataset contains all subsequences of length n, of all non-binding peptides.
For example, HEL 91-106 (SVNCAKKIVSDGDGMN) does not bind DR1. Thus, for n = 9, the subsequences SVNCAKKIV, VNCAKKIVS, NCAKKIVSD, CAK-KIVSDG, AKKIVSDGD, KKIVSDGDG, KIVSDGDGM and IVSDGDGMN are all entered into the non-binding dataset. All duplicate subsequences are deleted from the non-binding data-set. The 98 non-binding peptides produce 676 unique subsequences of length nine.
The binding data-set, on the other hand, is dynamic and changes from iteration to iteration. It is hoped that each successive iteration selects subsequences from the binding sequences that more accurately reflect the true binding motif. The initial binding data-set can be constructed on the basis of a suggested binding motif or reflect the entire database.
The initial binding data-set
The P1-P6 anchor motif utilized by Southwood et al. (1998) provides the initial estimate for the first model. A point is scored for Y, F, W, L, I, V or M in position 1, and S, T, C, A, P, V, I, L or M in position 6. For each binding peptide, the subsequence with the highest score is entered into the initial binding data-set. If the highest score is shared by more than one subsequence, they are all entered.
For example, the DR1 binder hemagglutinin 306-318 (PKYVKQNTLKLAT) has five subsequences of length nine. The subsequences and their scores are PKYVKQNTL (0),
, VKQNTLKLA (2) and KQNTLKLAT (0). Thus, YVKQNTLKL and VKQNTLKLA are both entered into the initial binding data-set. All duplicate subsequences are deleted from the initial binding data-set.
For the second model, the initial binding data-set is constructed without a suggested motif. In this method, similar to building the non-binding data-set, every subsequence from every binding peptide is entered into the initial binding dataset. Thus, for the binding peptide PKYVKQNTLKLAT, all five subsequences PKYVKQNTL, KYVKQNTLK, YVKQNTLKL, VKQNTLKLA and KQNTLKLAT enter the initial binding data-set. Again, duplicate subsequences are deleted from the initial binding data-set. In addition, all subsequences occurring in both the initial binding data-set and the non-binding data-set are deleted from the initial binding data-set.
Stepwise discriminant analysis
Given two mutually exclusive sets, stepwise discriminant analysis (SDA) (Dixon et al., 1990 ) builds a Bayesian discriminant function that classifies each element into one of the two sets. Specifically, an element is assigned to a set if the Bayesian posterior probability of belonging to that set exceeds the probability of belonging to the complementary set. Arguments for the function are selected from a list of potential predictor variables.
At
Step 0, an F statistic from a one-way analysis of variance is computed for each potential predictor variable to estimate which variable will most accurately separate the sets. The variable with the highest F-value is entered into the discriminant function. In a stepwise manner, additional variables are entered into the discriminant function until the Fvalues of all remaining variables are below a given minimum. In this study, the minimum F-value required for model entrance is set at 3.5.
The jack-knife method of cross-validation (Afif and Clark, 1990) is used. It is a special case of the general cross-validation method in which the classification functions are computed on a subset of cases, and the probability of misclassification is estimated from the remaining cases. In the jack-knife method, the first case is set aside while a classification function is computed on all remaining cases. The first case is evaluated by the classification function and tallied as being correctly or incorrectly classified. The process continues with the second case until each case has been left out in turn and classified.
In this study, the two mutually exclusive sets are the binding data-set of subsequences and the non-binding data-set of subsequences. For the purposes of SDA, elements of the binding dataset are assigned an outcome categorical value of 1 and elements of the non-binding data-set are assigned an outcome categorical value of 0.
The potential predictor variables for each case (subsequence) describe the biochemistry and position of each amino acid residue. If YVKQNTLKL is the subsequence of PKYVKQN-TLKLAT that binds DR1, the binding can be depicted by:
YVKQNTLKL
Predictor variables A1, C1, …, Y1 refer to amino acid residues in position 1; A2, C2, …, Y2 refer to residues in position 2, etc. The single-letter abbreviations for amino acid residues are ordered alphabetically. For a given case (subsequence), potential predictor variables are assigned a 1 if the designated residue occupies the position in question, a 0 if it does not.
For the current example, YVKQNTLKL, Y1 = V2 = K3 = Q4 = N5 = T6 = L7 = K8 = L9 = 1, while A1 … W1 = C2
When SDA is performed on the database of outcome variables and associated predictor variables, the result is a mathematical classification function of the form:
where i is the number of steps, v 1 through v i are the predictor variables selected by SDA, and b 0 through b i are coefficients determined by SDA. Subsequences in the binding data-set will generally have large values of u, while subsequences in the non-binding data-set will generally have small values of u.
A convenient aspect of SDA is that the classification function can be converted into the probability of set membership. The probability (P) that a subsequence belongs to the binding set is determined by the following equation:
The decision rule for classification is based on the probability of set membership. Most commonly, a value of P > 0.5 is utilized.
The iterative algorithm
A diagram of the iterative algorithm is shown in Figure 1 . It is first necessary to select a sequence length, n, as there will be a different resulting model for each value of n. The initial binding and non-binding data-sets are filled with subsequences of length n. SDA is performed utilizing the outcome and predictor variables defined above. While the non-binding data-set remains constant, the resulting SDA classification function is used to select the best subsequences for the next binding data-set. SDA is applied again and the process is repeated until the new classification function is the same as the previous function.
Algorithm implementation and results
For the model using the P1-P6 anchor motif as an initial estimate, the first application of SDA yields the following mathematical classification function which becomes the current model in the algorithm diagram: u = -5.78 + 1.14 A1 + 3. Since u(VKQNTLKLA) is the largest, VKQNTLKLA is entered into the current binding data-set. The current binding data-set is complete when this selection process has been repeated for all binding sequences. A new model is built using SDA, the current binding data-set and the stable non-binding data-set. The entire process is repeated until termination at the twelfth iteration, when the resulting new model is identical to the model of the eleventh iteration. The models are equal because the selected subsequences of the binding peptides have stabilized. Table 1 presents the final classification model using the P1-P6 anchor motif as the initial estimate, while Table 2 shows results using no initial motif. Two tables are presented to summarize the classification performance of the models. Both tables use the decision rule that P > 0.5 predicts that a subsequence will bind DR1. The results in Table 3 are taken directly from the computer output. Non-binders are reported as subsequences and jack-knife validation classifications are presented. Table 4 reports non-binders as peptides. The specificity and accuracy that are reported in Table 4 more realistically represent the true nature of the problem under investigation. However, there are no jack-knife results available for the peptide scenario because the computer program reports only summary results for the jack-knife procedure. As such, it is not possible to determine whether two missclassified subsequences belong to the same peptide or to different peptides. Thus, Table 3 evaluates the validity of the models, and Table 4 evaluates specificity and accuracy.
The suggested motif method and no motif method generate models with similar predictors (F1, V1, W1, Y1, A2, F2, K2, R2, V2, W2, Y2, F3, L3, Y3, A4, L4, M4, Q4, -G5, L5, M5, Y5, -E6, -K6, M6, -R6, -E7, G7, A8, L8, -N8, R8, A9, I9, L9 and R9) and similar performance. The fact that the two methods appear to converge suggests that the no motif method yields a realistic model.
Extending the list of possible predictors
The list of possible predictors can be augmented with dichotomous and continuous variables that characterize attributes of amino acid residues. Of the many schemes for grouping amino acids, the following was chosen for the purpose of illustration: It is not necessary that sets be mutually exclusive and collectively exhaustive as these are. Similar to the original set of predictor variables, ACID1, ALIP1, …, SULF1 refer to amino acid residues in position 1; ACID2, ALIP2, …, SULF2 refer to amino acid residues in position 2; etc. Potential predictor variables are assigned a 1 if a member of the named set occupies the position in question, a 0 if it does not. For the example YVKQNTLKL, AROM1 = ALIP2 = BASI3 = AMID4 = AMID5 = HYDR6 = ALIP7 = BASI8 = ALIP9 = 1. All other potential predictor variables in the extended list are set to 0.
Two new models for DR1 binding are developed using this extended list of predictors-the first utilizing the P1-P6 anchor motif, the second with no initial estimate. Table 5 and 6 present the final classification models, while Table 7 and 8 summarize the classification performance of both models along with jack-knife validation classifications.
Both models share the following characterization: Position 1 prefers AROMatic residues and V. Positions 2 and 3 are also AROMatic. Position 4 prefers A, L, M and Q, while position 5 accommodates M and Y, but not G. Position 9 prefers ALIPhatic residues. The fact that the negative coefficient for P has the same magnitude as the ALIPhatic coefficient suggests that ALIPhatic might be redefined without P.
This same characterization applies to the first two models produced without the extended predictor list. Since all four models classify the data equally well, it is left to future research to determine the optimal variation. 
Discussion
It is difficult to find studies with which to compare. Most studies evaluate a motif only on binding peptides and do not test the ability of the motif to identify non-binding peptides. O'Sullivan et al. (1991b) proposed the following DR1 binding motif:
W,F,Y,V,I,L in position 1; A,V,I,L,P,C,S,T in position 6; A,V,I,L,C,S,T,M,Y in position 9. They reported that the motif was present in 69% of good binders, 55% of intermediate binders, 31% of weak binders and 16.5% of negative binders.
Using an evolutionary algorithm and artificial neural network, Brusic et al. (1998) predicted HLA-DR4 binding. In binary classification, they correctly classified 100% of highaffinity binders, 82% of moderate-affinity binders, 30% of low affinity binders and 70% of non-binders. Southwood et al. (1998) experimentally developed a motif for DR4 binding. When tested on an independent set of 50 peptides, a conservative threshold resulted in sensitivity = 50.0%, specificity = 94.4% and accuracy = 82.0%, while a lower threshold resulted in sensitivity = 78.6%, specificity = 80.6% and accuracy = 80.0%.
The results of the present study compare favorably with these previous studies. Thus, the iterative SDA meta-algorithm is a promising tool for analyzing class II MHC molecular databases. This approach has the following advantages:
S
The resultant model is quantitative and easy to interpret.
The resultant model can be used to predict peptide binding.
The approach works with or without a suggested binding motif.
The approach is versatile and can include dichotomous or continuous properties of amino acid residues as possible predictors.
Classification results compare favorably with previous studies.
As with any data-driven algorithm, the results are data dependent and change when the data-sets change. However, as the data-sets grow, the sample space is better represented and the influence of individual peptides decreases.
